Gault Laura 4
4 · Sage Therapeutics, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4
Gault Laura
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-13+2,660→ 2,660 totalExercise: $45.28Exp: 2033-02-13→ Common Stock (2,660 underlying)
Footnotes (1)
- [F1]The securities awarded on February 13, 2023 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 665 shares of common stock shall vest on the one year anniversary of February 13, 2023, with 1,995 shares vesting in 36 equal monthly installments thereafter.